ctDNA Liquid Biopsy Predicts Colorectal Cancer Recurrence, But Acting on It Remains Contested
A landmark Viewpoint argues that the gap between ctDNA's prognostic power and clinical utility reflects misalignment of biology, timing, assay ...
Tag: ALTAIR
POPULAR NEWS
-
Reuse quality of open polymer datasets: a reproducible cross-repository audit (2020–2025)
-
ctDNA Liquid Biopsy Predicts Colorectal Cancer Recurrence, But Acting on It Remains Contested
-
Trust-aware graph network shows promise and limits in skin lesion classification
-
Process Mining Reveals Hidden Delays in Farm Software Development